Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
01 1Aptra Synthesis
02 1Innovassynth Technologies (I) Ltd
03 1SS Pharma
04 1Srini Pharmaceuticals
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
CAS Number : 873-74-5
End Use API :
End Use API : Dabigatran Etexilate Mesylate
About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP st...
CAS Number : 873-74-5
End Use API :
End Use API :
About the Company : Innovassynth Technologies (I) Ltd. formerly known as Chemicals Division of Indian Organic Chemicals Ltd. came in to existence since 1st August 2002. It is a part of the well-known busin...
CAS Number : 873-74-5
End Use API :
End Use API : Rilpivirine Hydrochloride
About the Company : Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Ca...
CAS Number : 873-74-5
End Use API :
End Use API : Dabigatran Etexilate Mesylate
About the Company : SS Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs), registered pharma intermediates, fine chemicals and pyridine derivatives for the domestic as well a...
